Avanos Medical, Inc. to Present at the UBS Healthcare Conference 2024

Rhea-AI Summary

Avanos Medical (NYSE: AVNS) has announced its participation in the UBS 2024 Healthcare Conference. Michael Greiner, the company's interim chief executive officer, will engage in a fireside chat on Tuesday, November 12 at approximately 2:45 p.m. Pacific Time. The presentation will be accessible via webcast through the Investors section of the Avanos Medical website, where it will also be archived for future reference.

News Market Reaction – AVNS

+1.37%

+1.37% Session move

In the trading session that priced this news, AVNS gained 1.37%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ALPHARETTA, Ga., Nov. 8, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in a fireside chat at the UBS 2024 Healthcare Conference on Tues., Nov. 12 at approximately 2:45 p.m. Pacific Time.

A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.

About Avanos Medical, Inc.

Avanos Medical, Inc. (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, we are committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. We develop, manufacture and market our recognized brands globally and hold leading market positions in multiple categories across our portfolio. For more information, visit Avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn and Facebook.

View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-ubs-healthcare-conference-2024-302300375.html

SOURCE Avanos Medical

FAQ

When is Avanos Medical (AVNS) presenting at the UBS Healthcare Conference 2024?

Avanos Medical (AVNS) will present at the UBS Healthcare Conference on Tuesday, November 12, 2024, at approximately 2:45 p.m. Pacific Time.

Who will represent Avanos Medical (AVNS) at the UBS Healthcare Conference 2024?

Michael Greiner, interim chief executive officer of Avanos Medical, will represent the company at the UBS Healthcare Conference 2024.

How can investors access Avanos Medical's (AVNS) UBS Healthcare Conference presentation?

Investors can access the presentation via webcast through the Investors section of the Avanos Medical website, where it will also be archived.

What type of presentation will Avanos Medical (AVNS) give at the UBS Healthcare Conference 2024?

Avanos Medical will participate in a fireside chat format presentation at the UBS Healthcare Conference 2024.